Skip to main content

FOR IMMEDIATE RELEASE:

SCRANTON, PA -- Educators and other professionals who diagnose and care for children and adults with fragile X syndrome are invited to attend a free conference presented by Geisinger’s Autism & Developmental Medicine Institute (ADMI).

Fragile X syndrome is a genetic condition that causes a range of developmental issues including learning disabilities and cognitive impairment. Males are usually more affected by the disorder and those affected usually have delayed development of speech and language by the age of 2.

“From the Clinic to the Classroom: Fragile X Syndrome” will be presented Oct. 7 at the University of Scranton in conjunction with the University’s Panuska College of Professional Studies and Scranton’s Friendship House.

The conference, which runs from 9 a.m. to noon, will provide training on how to help students with fragile X in a classroom setting. ADMI’s Brenda Finucane, M.S., LGC, will present Fragile X Syndrome: Diagnosis and Characteristics. Barbara Haas-Givler, M.Ed., BCBA, also of ADMI, will present Customizing the Learning Environment for School-Aged Students with Fragile X Syndrome.

While the conference is free, registration is required and begins at 8:30 a.m. at the University of Scranton Edward R. Leahy Jr. Hall, second floor forum, Room 235, 237 Jefferson Ave., Scranton. Advance registration is available online at www.regonline.com/fragilex. 

 

About Geisinger
One of the nation’s most innovative health services organizations, Geisinger serves more than 1.5 million patients in Pennsylvania and New Jersey. The system includes 13 hospital campuses, a nearly 600,000-member health plan, two research centers and the Geisinger Commonwealth School of Medicine. Geisinger is known for its focus on caring and innovative programs including the ProvenCare® best-practice approach to maximize quality, safety and value; ProvenHealth Navigator® advanced medical home; Springboard Health® population health program to improve the health of an entire community; ProvenExperience™ to provide refunds to patients unhappy with their care experience; and Geisinger’s MyCode® Community Health Initiative, the largest healthcare system-based precision health project in the world. With more than 215,000 volunteer participants enrolled, MyCode is conducting extensive research and returning medically actionable results to participants. A physician-led organization, with approximately 32,000 employees and more than 1,800 employed physicians, Geisinger leverages an estimated $12.7 billion positive annual impact on the Pennsylvania and New Jersey economies. Repeatedly recognized nationally for integration, quality and service, Geisinger has a long-standing commitment to patient care, medical education, research and community service. For more information, visit www.geisinger.org, or connect with us on Facebook, Instagram, LinkedIn and Twitter.